Denise Correa

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. ncbi Cognitive function and quality of life in ovarian cancer
    Denise D Correa
    Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Gynecol Oncol 124:404-9. 2012
  2. ncbi Cognitive functions in primary CNS lymphoma after single or combined modality regimens
    Denise D Correa
    Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Neuro Oncol 14:101-8. 2012
  3. ncbi Cognitive functions in long-term survivors of ovarian cancer
    Denise D Correa
    Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Gynecol Oncol 119:366-9. 2010
  4. ncbi Neurocognitive function in brain tumors
    Denise D Correa
    Department of Neurology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Curr Neurol Neurosci Rep 10:232-9. 2010
  5. ncbi Prospective cognitive follow-up in primary CNS lymphoma patients treated with chemotherapy and reduced-dose radiotherapy
    Denise D Correa
    Department of Neurology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    J Neurooncol 91:315-21. 2009
  6. ncbi Cognitive functions in primary central nervous system lymphoma: literature review and assessment guidelines
    D D Correa
    Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Ann Oncol 18:1145-51. 2007
  7. ncbi Cognitive functions in brain tumor patients
    Denise D Correa
    Department of Neurology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Hematol Oncol Clin North Am 20:1363-76. 2006
  8. ncbi Cognitive functions in low-grade gliomas: disease and treatment effects
    Denise D Correa
    Department of Neurology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    J Neurooncol 81:175-84. 2007
  9. ncbi Cognitive functions in primary central nervous system lymphoma patients treated with chemotherapy and stem cell transplantation: preliminary findings
    Denise Correa
    Department of Neurology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Clin Adv Hematol Oncol 1:490. 2003
  10. ncbi Cognitive functions in survivors of primary central nervous system lymphoma
    D D Correa
    Department of Neurology, Memorial Sloan Kettering Cancer Center, New York 10021, USA
    Neurology 62:548-55. 2004

Detail Information

Publications22

  1. ncbi Cognitive function and quality of life in ovarian cancer
    Denise D Correa
    Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Gynecol Oncol 124:404-9. 2012
    ..The aim of this study was to review the literature on cognitive function and quality of life (QOL) in this population...
  2. ncbi Cognitive functions in primary CNS lymphoma after single or combined modality regimens
    Denise D Correa
    Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Neuro Oncol 14:101-8. 2012
    ..Cognitive dysfunction was more prevalent in PCNSL survivors treated with WBRT + HD-MTX compared with patients treated with HD-MTX alone...
  3. ncbi Cognitive functions in long-term survivors of ovarian cancer
    Denise D Correa
    Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Gynecol Oncol 119:366-9. 2010
    ..This cross-sectional study assessed neuropsychological functions in long-term survivors of ovarian cancer who were either in complete remission or with evidence of recurrent disease...
  4. ncbi Neurocognitive function in brain tumors
    Denise D Correa
    Department of Neurology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Curr Neurol Neurosci Rep 10:232-9. 2010
    ..Although there are no established preventive or therapeutic interventions for treatment-induced cognitive dysfunction, this is an area of growing interest, and several approaches are currently under investigation...
  5. ncbi Prospective cognitive follow-up in primary CNS lymphoma patients treated with chemotherapy and reduced-dose radiotherapy
    Denise D Correa
    Department of Neurology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    J Neurooncol 91:315-21. 2009
    ..There was no significant cognitive decline up to 24 months post-chemotherapy and reduced-dose WBRT in this group of PCNSL patients, however, difficulties in Verbal Memory and Motor speed persisted over the follow-up period...
  6. ncbi Cognitive functions in primary central nervous system lymphoma: literature review and assessment guidelines
    D D Correa
    Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Ann Oncol 18:1145-51. 2007
    ..There is, however, a paucity of research on cognitive functions in this population...
  7. ncbi Cognitive functions in brain tumor patients
    Denise D Correa
    Department of Neurology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Hematol Oncol Clin North Am 20:1363-76. 2006
    ..Future prospective clinical trials in neuro-oncology should include cognitive outcome measures to increase understanding of the contribution of the tumor and the delayed effects of treatment to cognitive dysfunction...
  8. ncbi Cognitive functions in low-grade gliomas: disease and treatment effects
    Denise D Correa
    Department of Neurology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    J Neurooncol 81:175-84. 2007
    ..The few published studies examining adverse treatment effects on cognition revealed conflicting results...
  9. ncbi Cognitive functions in primary central nervous system lymphoma patients treated with chemotherapy and stem cell transplantation: preliminary findings
    Denise Correa
    Department of Neurology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Clin Adv Hematol Oncol 1:490. 2003
  10. ncbi Cognitive functions in survivors of primary central nervous system lymphoma
    D D Correa
    Department of Neurology, Memorial Sloan Kettering Cancer Center, New York 10021, USA
    Neurology 62:548-55. 2004
    ..This combined regimen prolongs patient survival, but also carries a substantial risk for delayed neurotoxicity particularly in the elderly. However, cognitive outcome evaluations have not been included in most clinical trials...
  11. ncbi An integrated functional magnetic resonance imaging procedure for preoperative mapping of cortical areas associated with tactile, motor, language, and visual functions
    J Hirsch
    Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Neurosurgery 47:711-21; discussion 721-2. 2000
    ..To evaluate an integrated battery of preoperative functional magnetic resonance imaging (fMRI) tasks developed to identify cortical areas associated with tactile, motor, language, and visual functions...
  12. ncbi Concordance between functional magnetic resonance imaging and intraoperative language mapping
    M I Ruge
    Department of Neurology, Memorial Sloan Kettering Cancer Center, Weill Medical College of Cornell University, New York, NY, USA
    Stereotact Funct Neurosurg 72:95-102. 1999
    ..When responses were obtained with both methods, localization of function concurred in all cases. These observations suggest that fMRI represents a reliable preoperative tool for the identification of language-sensitive areas...
  13. ncbi Cognitive effects of hormonal therapy in older adults
    Nicholas Mitsiades
    Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Semin Oncol 35:569-81. 2008
    ....
  14. ncbi Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysis
    Lauren E Abrey
    Departments of Neurology and Medicine and the Office of Clinical Research, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 21:4151-6. 2003
    ..To assess the safety and efficacy of intensive methotrexate-based chemotherapy followed by high-dose chemotherapy (HDT) with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma (PCNSL)...
  15. ncbi Imaging neurotoxicity: is a picture worth a thousand words?
    Denise D Correa
    AJNR Am J Neuroradiol 26:205-6. 2005
  16. ncbi Phase I/II study of weekly paclitaxel plus carboplatin and gemcitabine as first-line treatment of advanced-stage ovarian cancer: pathologic complete response and longitudinal assessment of impact on cognitive functioning
    Martee L Hensley
    Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 275 York Avenue, New York, NY 10021, USA
    Gynecol Oncol 102:270-7. 2006
    ....
  17. ncbi Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma
    Gaurav D Shah
    Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 25:4730-5. 2007
    ....
  18. ncbi Longitudinal cognitive follow-up in low grade gliomas
    Denise D Correa
    Department of Neurology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    J Neurooncol 86:321-7. 2008
    ....
  19. ncbi Treatment-related neurotoxicity
    Lauren E Abrey
    Department of Neurology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Hematol Oncol Clin North Am 19:729-38, viii. 2005
    ..Long-term follow up of prospective therapeutic studies should report on both disease control and the development of neurotoxicity. New protocols should include prospective longitudinal measures of neurocognitive function...
  20. ncbi Delayed neurotoxicity in primary central nervous system lymphoma
    Antonio M P Omuro
    Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
    Arch Neurol 62:1595-600. 2005
    ....
  21. ncbi Discordance between functional magnetic resonance imaging during silent speech tasks and intraoperative speech arrest
    Nicole Petrovich
    Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    J Neurosurg 103:267-74. 2005
    ..The control fMR imaging study showed that vocalized speech fMR imaging shifts the location of the fMR imaging prediction to include the motor strip and may be more appropriate for neurosurgical planning...
  22. ncbi Cognitive adverse effects of chemotherapy in breast cancer patients
    Denise D Correa
    Department of Neurology, Memorial Sloan Kettering Cancer Center, New York 10022, USA
    Curr Opin Support Palliat Care 1:57-62. 2007
    ..This article reviews the most recent literature on chemotherapy-associated cognitive changes in women with breast cancer...